E75 + GM-CSF vaccine

BIOLOGICAL2 trials

Sponsors

COL George Peoples, MD, FACS

Conditions

Breast Cancer

Phase 1

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

CompletedNCT00841399

COL George Peoples, MD, FACSBreast Cancer

Start: 2001-07-31End: 2013-03-31Updated: 2020-03-31

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer

CompletedNCT00854789

COL George Peoples, MD, FACSBreast Cancer

Start: 2002-12-31End: 2013-03-31Updated: 2020-03-31

Related Papers

Effect of novel peptide vaccines on secondary recurrences and survivorship.

Journal of Clinical Oncology2016-01-20

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients.

2014-06-06183 citations